Metaphore Biotechnologies Announces Formation of Scientific Advisory Board to Advance the Next Era of Antibody Medicines
Metaphore Biotechnologies (“Metaphore”), a Flagship Pioneering company creating new antibody-based medicines, today announced the formation of its Scientific Advisory Board (SAB). The SAB brings expertise across protein engineering, AI/ML, immunology, metabolism, and biologics development as Metaphore advances its integrated experimental and computational antibody design platform and initial pipeline of therapeutics to the clinic.
